ID

26197

Descrizione

Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Liver events

Keywords

versioni (5)
  1. 11/10/17 11/10/17 -
  2. 16/10/17 16/10/17 -
  3. 16/10/17 16/10/17 -
  4. 23/10/17 23/10/17 -
  5. 11/01/18 11/01/18 -
Titolare del copyright

GlaxoSmithKline

Caricato su

11 ottobre 2017

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Liver events GSK study Chronic Coronary Heart Disease NCT00799903

Inglese

Liver events GSK study Chronic Coronary Heart Disease NCT00799903

1 moduli  
1. Which liver chemistry result reached or exceeded protocol-defined investigational product stopping criteria?
Descrizione

1. Which liver chemistry result reached or exceeded protocol-defined investigational product stopping criteria?

[1] ALT (alanine aminotransferase)
Descrizione

alanine aminotransferase

Tipo di dati

boolean

[2] AST (aspartate aminotransferase)
Descrizione

aspartate aminotransferase

Tipo di dati

boolean

[3] Total bilirubin
Descrizione

Total bilirubin

Tipo di dati

boolean

[4] Alkaline phosphatase
Descrizione

Alkaline phosphatase

Tipo di dati

boolean

[OT] Other
Descrizione

Other liver chemistry result

Tipo di dati

boolean

Liver events
Descrizione

Liver events

2. Is the subject age 55 or older?
Descrizione

subject age

Tipo di dati

boolean

3. If female, is the subject pregnant?
Descrizione

If yes, ensure Pregnancy Notification Form has been completed.

Tipo di dati

text

4. Were any diagnostic imaging tests of the liver or hepatobiliary system performed (such as liver ultrasound, computerised tomography or CAT scan, magnetic resonance imaging or MRI, or endoscopic retrograde cholangiopancreatography, or other)?
Descrizione

diagnostic imaging of liver or hepatobiliary system

Tipo di dati

boolean

4. If diagnostic imaging tests were performed, were the results normal?
Descrizione

If No, record the details on the Non-Serious Adverse Events form or Serious Adverse Event form.

Tipo di dati

boolean

5. Were any liver biopsies performed?
Descrizione

If yes, complete Liver Biopsy form.

Tipo di dati

boolean

6. Does the subject use herbals, complementary or alternative medicines, food supplements (vitamins) or illicit drugs?
Descrizione

If yes, record on the appropriate Concomitant Medication form.

Tipo di dati

boolean

7. Did the subject fast or undergo significant dietary change in the past week?
Descrizione

dietary change

Tipo di dati

boolean

Evaluation interval code
Descrizione

[hidden]

Tipo di dati

text

Ritorna all'inizio della pagina

Similar models

Liver events GSK study Chronic Coronary Heart Disease NCT00799903

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
1. Which liver chemistry result reached or exceeded protocol-defined investigational product stopping criteria?
alanine aminotransferase
Item
[1] ALT (alanine aminotransferase)
boolean
aspartate aminotransferase
Item
[2] AST (aspartate aminotransferase)
boolean
Total bilirubin
Item
[3] Total bilirubin
boolean
Alkaline phosphatase
Item
[4] Alkaline phosphatase
boolean
Other liver chemistry result
Item
[OT] Other
boolean
Item Group
Liver events
subject age
Item
2. Is the subject age 55 or older?
boolean
Item
3. If female, is the subject pregnant?
text
subject pregnant
Code List
3. If female, is the subject pregnant?
CL Item
Yes (Y)
CL Item
No (N)
CL Item
Not applicable (X)
diagnostic imaging of liver or hepatobiliary system
Item
4. Were any diagnostic imaging tests of the liver or hepatobiliary system performed (such as liver ultrasound, computerised tomography or CAT scan, magnetic resonance imaging or MRI, or endoscopic retrograde cholangiopancreatography, or other)?
boolean
diagnostic imaging of liver or hepatobiliary system results
Item
4. If diagnostic imaging tests were performed, were the results normal?
boolean
liver biopsies
Item
5. Were any liver biopsies performed?
boolean
complementary or alternative medicines, supplements, illicit drugs
Item
6. Does the subject use herbals, complementary or alternative medicines, food supplements (vitamins) or illicit drugs?
boolean
dietary change
Item
7. Did the subject fast or undergo significant dietary change in the past week?
boolean
Evaluation interval code
Item
Evaluation interval code
text
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial